Holen Sie sich die Stockscreener-App
2.33
0.87%
0.02
Handel nachbörslich:
2.30
-0.03
-1.29%
Mangoceuticals Inc Aktie (MGRX) Neueste Nachrichten
Mangoceuticals Inc. (MGRX) Quarterly 10-Q Report - Quartzy
Mangoceuticals Signs Consulting Deal with CFO Johnston - TipRanks
Mangoceuticals (MGRX) versus Its Competitors Head-To-Head Contrast - Defense World
Financial Comparison: Mangoceuticals (MGRX) versus Its Competitors - Defense World
Mangoceuticals (MGRX) and The Competition Head-To-Head Comparison - Defense World
Head to Head Survey: Mangoceuticals (MGRX) vs. The Competition - Defense World
Head to Head Review: Mangoceuticals (MGRX) versus Its Competitors - Defense World
Head-To-Head Analysis: Mangoceuticals (MGRX) vs. The Competition - Defense World
Mangoceuticals (MGRX) & Its Competitors Head to Head Comparison - Defense World
Reviewing Mangoceuticals (MGRX) & Its Competitors - Defense World
Financial Survey: Mangoceuticals (MGRX) & Its Competitors - Defense World
Mangoceuticals (MGRX) versus Its Peers Head to Head Comparison - Defense World
Mangoceuticals (MGRX) & Its Competitors Financial Analysis - Defense World
Head-To-Head Contrast: Mangoceuticals (MGRX) & The Competition - Defense World
Mangoceuticals (MGRX) versus The Competition Head to Head Survey - Defense World
Reviewing Mangoceuticals (MGRX) & Its Rivals - Defense World
Mangoceuticals (NASDAQ:MGRX) Regains Compliance with Nasdaq Minimum Bid Price Requirement - Defense World
Head to Head Analysis: Mangoceuticals (NASDAQ:MGRX) & NewGenIvf Group (NASDAQ:NIVF) - Defense World
Head to Head Review: Mangoceuticals (MGRX) & Its Rivals - Defense World
Financial Analysis: Mangoceuticals (MGRX) vs. Its Peers - Defense World
Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewswire
Mangoceuticals regains full compliance with Nasdaq min bid price requirement - TipRanks
Analyzing Mangoceuticals (MGRX) and Its Competitors - Defense World
Mangoceuticals (MGRX) and Its Peers Financial Comparison - Defense World
Head-To-Head Contrast: Mangoceuticals (MGRX) & Its Peers - Defense World
Head to Head Analysis: Mangoceuticals (MGRX) vs. Its Competitors - Defense World
Financial Review: Mangoceuticals (MGRX) & Its Peers - Defense World
Comparing Mangoceuticals (MGRX) and Its Peers - Defense World
Mangoceuticals issues shares, raises $78,787 in capital By Investing.com - Investing.com South Africa
Head to Head Analysis: Mangoceuticals (NASDAQ:MGRX) vs. NewGenIvf Group (NASDAQ:NIVF) - Defense World
Mangoceuticals issues shares, raises $78,787 in capital - Investing.com India
Reviewing Mangoceuticals (MGRX) & The Competition - Defense World
Mangoceuticals (MGRX) & Its Rivals Critical Comparison - Defense World
Comparing Mangoceuticals (MGRX) & Its Rivals - Defense World
Mangoceuticals Responds to Claims Made by Eli Lilly in Recent Press Release - Defense World
Head to Head Review: Mangoceuticals (MGRX) versus Its Rivals - Defense World
Mangoceuticals explores strategic alternatives to boost shareholder value By Investing.com - Investing.com Australia
Mangoceuticals explores strategic alternatives to boost shareholder value - Investing.com
MangoRx Announces Formation of Strategy and Alternatives Committee - GlobeNewswire
Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit - MSN
Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit (NASDAQ:MGRX) - Seeking Alpha
Mangoceuticals Board Initiates Process to Evaluate Strategic Alternatives - Marketscreener.com
Mangoceuticals Defends Against Eli Lilly Allegations - TipRanks
MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly - ForexTV.com
MangoRx faces lawsuit from Eli Lilly over medication - Investing.com
Mangoceuticals ‘refutes’ claims by Eli Lilly regarding sale of tirzepatide - TipRanks
0.40%
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):